log in
Print | Back

Dykema

Jonathan S. Feld

Jonathan S. Feld

Member

Expertise

  • Business & Commercial
  • Cybersecurity
  • Appellate
  • Antitrust & Trade Regulation

WSG Practice Industries

Activity

Dykema
Illinois, U.S.A.

Profile

Jonathan S. Feld is the Leader of the Government Investigations and Corporate Compliance Team. He is located in Dykema’s Chicago office as well as the Firm’s Washington, D.C. office. 

Mr. Feld’s practice focuses on complex civil and criminal matters, including health care, financial, antitrust, government contracting and antibribery investigations. He represents companies, directors and officers in investigations and enforcement actions by the U.S. Department of Justice (DOJ), Securities and Exchange Commission (SEC), the Food and Drug Administration (FDA) and Office of Inspectors General (OIG) of other regulatory agencies. Mr. Feld advises corporations, boards of directors and board committees regarding internal investigations, corporate compliance programs and corporate governance issues, including the Foreign Corrupt Practices Act (FCPA) and data privacy.

Mr. Feld's work encompasses False Claims Act litigation in a variety of industries including health care, manufacturing, and consumer finance. He also represents parties in class actions, arbitrations, and commercial litigation.

Mr. Feld served at the DOJ as an Associate Deputy Attorney General. In that role, he oversaw prosecutions from U.S. Attorney's offices nationwide involving a broad array of cases from financial institution fraud to securities matters to environmental prosecutions. He was an Assistant U.S. Attorney for the District of New Jersey, where he concentrated on financial and securities prosecutions and other complex white collar criminal matters. He twice received DOJ Special Achievement awards.

Mr. Feld served as Assistant Special Counsel to the Select Commission established by the State of Rhode Island to investigate the collapse of its multibillion dollar privately-insured financial institution system. In addition, he served as an Associate Independent Counsel for the investigation of the U.S. Department of Housing and Urban Development under the direction of the Hon. Arlin Adams.

Mr. Feld serves on the Board of Editors for Business Crimes Bulletin, a monthly publication about corporate compliance and investigations.

Bar Admissions

Illinois

Michigan

District of Columbia

New York

Education

Boston University School of Law, J.D.
  • Law Review
Harvard University, M.C.R.P. Reed College, B.A.
  • Phi Beta Kappa
Areas of Practice

Antitrust & Trade Regulation | Appellate | Appellate and Complex Motion Practice | Business & Commercial | Cybersecurity | FDA Regulatory | Food & Beverage | Government Investigations and Corporate Compliance | Government Reorganization and Restructuring | Health Care | Litigation | Privacy and Data Security | Privacy, Data Security & E-Commerce | Securities Litigation | Specialized Litigation & Advanced Motion Practice Team | White-Collar Criminal Defense & Government Investigations

Professional Career

Significant Accomplishments

Representation of hospitals in a multimillion False Claims Act settlements.
Representation of a regulatory director in a criminal FDA prosecution including an off-label marketing violation.
Representation of senior officer of an internet company in securities prosecution.
Representation of physicians in antikickback investigations.
Representation of a multinational foreign company in an antitrust investigation and class action litigation.
Representation of manufacturing, healthcare, technology and financial services companies in internal investigations
Articles

Supreme Court Rejects Third Challenge To Affordable Care Act
Dykema, June 2021

On June 17, the Supreme Court rejected another court challenge to the Affordable Care Act (“ACA”), holding that the plaintiffs lacked standing to challenge its minimum essential coverage provisions. For the third time, the Supreme Court upheld the ACA. More than a decade after the ACA was enacted, the long and winding road of ACA challenges may be over and healthcare industry participants may finally be able to rely on the ACA as settled law moving forward...

Change is Near: What the Biden Executive Order Means for Title IX Misconduct Claims
Dykema, March 2021

On March 8, President Biden took his first steps in reversing the Trump Administration’s Title IX policy by issuing an Executive Order 14021 (“Order”) directing the Secretary of Education to review the Title IX rules issued by the Trump Administration...

Adding up the Numbers: DOJ Announces Its False Claims Act Recoveries for 2020
Dykema, February 2021

In January 2021, the U.S. Dept. of Justice (DOJ) announced $2.2 billion in False Claims Act (FCA) recoveries for fiscal year 2020, which ended on September 30.[1] Although this amount is substantial, it nonetheless represents the smallest recovery figure in 10 years. These figures reflect the Trump administration’s unaggressive enforcement efforts and its restrictive view of the FCA. As recently as 2016, FCA recovery exceeded $4.5 billion. Recoveries in 2019 were $3...

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2021